Commission incorporates Parliament views in revised FP7 proposal

The European Commission has adopted an amended proposal for the Seventh Framework Programme (FP7), which seeks to incorporate amendments made by the European Parliament and the Council of Ministers in their first readings. The Commission reports that the revised proposals "take up in spirit and content if not necessarily always with the exact wording, to a large proportion the position taken by the other institutions".

The Commission adopted its original FP7 proposal in April 2005, while the budgetary aspects to the programme were adopted in May 2006, following agreement on the EU's Financial Perspectives for 2007 to 2013. The Parliament adopted the proposals by a broad majority in June 2006, proposing some 1700 amendments.

The themes set to receive funding under the Cooperation programme remain the same, with a number of clarifications, specifying areas in which research will be funded. These range from healthy ageing and infectious diseases to soil fertility, the sustainability of fisheries, platforms for software and services and nano-composites.

On Joint Technology Initiatives (JTIs), long-term public-private partnerships to boost technology in specific fields, the Commission accepts modifications on the criteria to be used for identifying potential JTIs, as well as their organisation and implementation.

For example, the new proposal adds that when assessing the need for a JTI: the existence of a genuine societal need and benefit; the scale of the impact on industrial competitiveness and growth; and the inability of existing instruments to achieve the objective should all be taken into account.

The amended proposal also emphasises that small and medium sized enterprises (SMEs), technology transfer and education should not be neglected by JTIs. The organisation of JTIs should ensure that "participation in their projects is open to a wide range of participants throughout Europe, and in particular SMEs".

The Commission also incorporates important clarifications on the European Research Council (ERC), and in particular on the term of office, the renewal and the role of the Scientific Council, the management and staffing arrangements, and the independent review of the ERC.

MEPs had requested a review of the ERC in 2008. Speaking to the Parliament during a debate on FP7, EU Science and Research Commissioner Janez Potocnik suggested that this would be too soon. The revised proposal states that the review will be carried out 'no later than 2010'.

The new document adds that the ERC shall have the ability to conduct its own strategic studies to prepare and support its operational activities.

Ethics were a major consideration for many parliamentarians, and the revised proposal seeks to allay concerns by specifying which areas will not receive any funding under FP7. These are human cloning for reproductive purposes, research intended to modify the genetic heritage of human beings which could make such changes heritable, and research intended to create human embryos solely for the purpose of research or the purpose of stem cell procurement.

To follow the debate on FP7, please visit:

http://cordis.europa.eu/fp7/home.html

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...